{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Social+Status+Condition", "query": { "intervention": "Low Social Status Condition" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 91, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Low+Social+Status+Condition&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-16T13:39:23.649Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06666192", "title": "The Ohio State University (OSU) SCREEN Community Program", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma", "Cervical Carcinoma", "Colorectal Carcinoma" ], "interventions": [ { "name": "Cancer Screening", "type": "OTHER" }, { "name": "Discussion", "type": "OTHER" }, { "name": "Educational Activity", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Focus Group", "type": "BEHAVIORAL" }, { "name": "Health Care Delivery", "type": "OTHER" }, { "name": "Health Promotion", "type": "OTHER" }, { "name": "Health Promotion and Education", "type": "OTHER" }, { "name": "Health Risk Assessment", "type": "BEHAVIORAL" }, { "name": "Implementation", "type": "PROCEDURE" }, { "name": "Informational Intervention", "type": "OTHER" }, { "name": "Internet-Based Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Outreach", "type": "BEHAVIORAL" }, { "name": "Patient Navigation", "type": "BEHAVIORAL" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2067, "start_date": "2024-03-12", "completion_date": "2029-12-31", "has_results": false, "last_update_posted_date": "2025-12-24", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06666192" }, { "nct_id": "NCT00624650", "title": "Hemodynamics and Extravascular Lung Water in Acute Lung Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Lung Injury" ], "interventions": [ { "name": "Diuresis (furosemide) part I", "type": "DRUG" }, { "name": "Fluid Bolus (crystalloid or albumin)", "type": "OTHER" }, { "name": "Vasopressors (Norepinephrine, Vasopressin, Phenylephrine, Epinephrine)", "type": "DRUG" }, { "name": "Dobutamine", "type": "DRUG" }, { "name": "Concentrate all drips and nutrition", "type": "OTHER" }, { "name": "Diuresis (furosemide) part II", "type": "DRUG" }, { "name": "Dialysis", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2008-02", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2019-09-10", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 3, "location_summary": "Clackamas, Oregon • Portland, Oregon", "locations": [ { "city": "Clackamas", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624650" }, { "nct_id": "NCT03010774", "title": "Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sleep Quality" ], "interventions": [ { "name": "Risk Stratification", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 166, "start_date": "2017-02-14", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2020-03-27", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03010774" }, { "nct_id": "NCT03952637", "title": "A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Lysosomal Diseases", "Gangliosidosis", "GM1" ], "interventions": [ { "name": "AAV9-GLB1", "type": "BIOLOGICAL" }, { "name": "Abdominal ultrasound", "type": "PROCEDURE" }, { "name": "Rituximab", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Audiology assessment with ABR", "type": "DIAGNOSTIC_TEST" }, { "name": "Bone density scan (DEXA)", "type": "DIAGNOSTIC_TEST" }, { "name": "Electrocardiogram (EKG)", "type": "DIAGNOSTIC_TEST" }, { "name": "Echocardiogram", "type": "DIAGNOSTIC_TEST" }, { "name": "Electroencephalogram (EEG) awake and extended overnight", "type": "OTHER" }, { "name": "Laboratory tests", "type": "DIAGNOSTIC_TEST" }, { "name": "Lumbar puncture", "type": "PROCEDURE" }, { "name": "Brain MRI/MRS/fMRI", "type": "PROCEDURE" }, { "name": "Neurocognitive testing", "type": "BEHAVIORAL" }, { "name": "Neurology exam", "type": "OTHER" }, { "name": "PICC or other Central line placement", "type": "BEHAVIORAL" }, { "name": "Skeletal survey", "type": "PROCEDURE" }, { "name": "Skin biopsy", "type": "PROCEDURE" }, { "name": "Speech and modified barium swallow study", "type": "PROCEDURE" }, { "name": "Ophthalmology exam", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG", "DIAGNOSTIC_TEST", "OTHER", "BEHAVIORAL" ], "sponsor": "National Human Genome Research Institute (NHGRI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Months to 12 Years" }, "enrollment_count": 54, "start_date": "2019-08-19", "completion_date": "2030-01-01", "has_results": false, "last_update_posted_date": "2026-09-11", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03952637" }, { "nct_id": "NCT00801801", "title": "Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non Squamous Cell Lung Cancer", "Non Small Cell Lung Cancer" ], "interventions": [ { "name": "Docetaxel + Sorafenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Francisco Robert,MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 5, "start_date": "2008-01", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2017-05-17", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00801801" }, { "nct_id": "NCT06808490", "title": "Exercise and Endocannabinoids for Brain and Mental Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Children", "Adolescents" ], "interventions": [ { "name": "Moderate Intensity Exercise", "type": "BEHAVIORAL" }, { "name": "Light Intensity Stretching", "type": "BEHAVIORAL" }, { "name": "Seated Meditation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Wayne State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "9 Years to 17 Years" }, "enrollment_count": 68, "start_date": "2021-12-21", "completion_date": "2024-03-18", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06808490" }, { "nct_id": "NCT06601933", "title": "Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Cognitive Impairment (MCI)", "Cognitive Training" ], "interventions": [ { "name": "Cognitive Training", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "55 Years to 89 Years" }, "enrollment_count": 240, "start_date": "2024-12-17", "completion_date": "2030-08-31", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 4, "location_summary": "Miami, Florida • New York, New York • Durham, North Carolina + 1 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06601933" }, { "nct_id": "NCT01928485", "title": "Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stage I Prostate Cancer", "Stage IIA Prostate Cancer", "Stage IIB Prostate Cancer" ], "interventions": [ { "name": "active surveillance", "type": "OTHER" }, { "name": "Sunphenon", "type": "DRUG" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Sanjay Gupta PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "85 Years", "sex": "MALE", "summary": "45 Years to 85 Years · Male only" }, "enrollment_count": 6, "start_date": "2013-08-30", "completion_date": "2016-11-07", "has_results": true, "last_update_posted_date": "2020-10-22", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01928485" }, { "nct_id": "NCT00802204", "title": "Dopamine and Insulin Resistance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "PET scan", "type": "RADIATION" }, { "name": "Oral glucose tolerance test", "type": "PROCEDURE" }, { "name": "MRI", "type": "PROCEDURE" }, { "name": "Psychological scales to assess attitudes and behaviors related to eating and quality of life", "type": "BEHAVIORAL" }, { "name": "Caloric Restriction", "type": "OTHER" } ], "intervention_types": [ "RADIATION", "PROCEDURE", "BEHAVIORAL", "OTHER" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 28, "start_date": "2008-12", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2017-05-10", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802204" }, { "nct_id": "NCT03619798", "title": "Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Diagnoses Disease" ], "interventions": [ { "name": "HemoTypeSC", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Silver Lake Research Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 600, "start_date": "2018-08-03", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2018-08-08", "last_synced_at": "2026-09-16T13:39:23.649Z", "location_count": 1, "location_summary": "Azusa, California", "locations": [ { "city": "Azusa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03619798" } ] }